title: Bulimia nervosa, 5-HTTLPR polymorphism and treatment response to four SSRIs: a single-blind study.
authors.forename: Stefano
authors.initials: S
authors.lastname: Erzegovesi
authors.forename: Chiara
authors.initials: C
authors.lastname: Riboldi
authors.forename: Daniela
authors.initials: D
authors.lastname: Di Bella
authors.forename: Daniela
authors.initials: D
authors.lastname: Di Molfetta
authors.forename: Francesca
authors.initials: F
authors.lastname: Mapelli
authors.forename: Bruna
authors.initials: B
authors.lastname: Negri
authors.forename: Micaela
authors.initials: M
authors.lastname: Tenace
authors.forename: Laura
authors.initials: L
authors.lastname: Bellodi
mesh_terms: D000293:Adolescent; D000328:Adult; D002032:Bulimia / Q000188:drug therapy* / Q000235:genetics*; D006801:Humans; D008562:Membrane Glycoproteins / Q000235:genetics*; D026901:Membrane Transport Proteins / Q000235:genetics*; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics*; D011110:Polymorphism, Genetic / Q000187:drug effects / Q000235:genetics*; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D016037:Single-Blind Method
chemical_list: D008562:Membrane Glycoproteins; D026901:Membrane Transport Proteins; D009419:Nerve Tissue Proteins; D050486:Serotonin Plasma Membrane Transport Proteins; D017367:Selective Serotonin Reuptake Inhibitors; C493230:SLC6A4 protein, human